Nanobiotix, a biotechnology company, disclosed its voting rights and share capital as of August 31, 2025. With 48,236,771 shares outstanding, they have a total of 50,337,954 theoretical voting rights and 50,315,836 exercisable voting rights. Founded in 2003, Nanobiotix is headquartered in Paris, listed on Euronext Paris and Nasdaq, with subsidiaries in Cambridge, MA. The company owns over 25 patent families related to nanotechnology platforms for oncology, bioavailability, and CNS disorders. For more information, visit their website or follow them on LinkedIn and Twitter. Contact their communication, investor relations, or media relations departments for inquiries.

Read more at GlobeNewswire: Voting Rights and Shares Capital of the Company